Literature DB >> 9094664

Phage-displayed peptide targeting on the Puumala hantavirus neutralization site.

T Heiskanen1, A Lundkvist, A Vaheri, H Lankinen.   

Abstract

We have selected ligands for Puumala hantavirus, the causative agent of nephropathia epidemica, from a seven-amino-acid peptide library flanked by cysteines and displayed on a filamentous phage. To direct the selection to areas on the virus particle which are essential for infection, phages were competitively eluted with neutralizing monoclonal antibodies specific for the viral glycoproteins. The selected phage populations were specific for the same sites as the antibodies and mimicked their functions. The peptide insert, CHWMFSPWC, when displayed on the phages, completely inhibited Puumala virus infection in cell culture at the same effective concentration as the eluting antibody specific for envelope glycoprotein G2. The binding of the phage clones to the virus and inhibition of infection were not necessarily coincident; Pro-6 was critical for virus inhibition, while consensus residues Trp-2 and Phe-4 were essential for binding. The strategy described can be applied to any virus for production of molecules mimicking the effect of neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094664      PMCID: PMC191539     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  Searching for peptide ligands with an epitope library.

Authors:  J K Scott; G P Smith
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

3.  Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.

Authors:  C S Schmaljohn; Y K Chu; A L Schmaljohn; J M Dalrymple
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

Review 4.  Molecular biology of the Bunyaviridae.

Authors:  R M Elliott
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

Review 5.  Hantaviruses: genome structure, expression and evolution.

Authors:  A Plyusnin; O Vapalahti; A Vaheri
Journal:  J Gen Virol       Date:  1996-11       Impact factor: 3.891

6.  Detection of hemagglutination-inhibiting antibodies in patients with nephropathia epidemica and Korean hemorrhagic fever by using Puumala virus cell culture antigen.

Authors:  M Brummer-Korvenkontio; T Manni; S Ukkonen; A Vaheri
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

7.  Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies.

Authors:  J Arikawa; A L Schmaljohn; J M Dalrymple; C S Schmaljohn
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

8.  Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies.

Authors:  A Lundkvist; A Fatouros; B Niklasson
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

Review 9.  Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome.

Authors:  T M Cosgriff
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

10.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

View more
  8 in total

1.  Interactions and oligomerization of hantavirus glycoproteins.

Authors:  Jussi Hepojoki; Tomas Strandin; Antti Vaheri; Hilkka Lankinen
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 2.  Phage-displayed peptide libraries.

Authors:  M B Zwick; J Shen; J K Scott
Journal:  Curr Opin Biotechnol       Date:  1998-08       Impact factor: 9.740

3.  Characterization of neutralizing antibodies and identification of neutralizing epitope mimics on the Clostridium botulinum neurotoxin type A.

Authors:  H C Wu; C T Yeh; Y L Huang; L J Tarn; C C Lung
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

4.  An artificial cell-cycle inhibitor isolated from a combinatorial library.

Authors:  B A Cohen; P Colas; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

5.  Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2.

Authors:  Carolina de la Guardia; Mario Quijada; Ricardo Lleonart
Journal:  Adv Virol       Date:  2017-09-10

Review 6.  Humoral Immunity to Hantavirus Infection.

Authors:  Taylor B Engdahl; James E Crowe
Journal:  mSphere       Date:  2020-07-15       Impact factor: 4.389

7.  Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein.

Authors:  Ilona Rissanen; Robert Stass; Stefanie A Krumm; Jeffrey Seow; Ruben Jg Hulswit; Guido C Paesen; Jussi Hepojoki; Olli Vapalahti; Åke Lundkvist; Olivier Reynard; Viktor Volchkov; Katie J Doores; Juha T Huiskonen; Thomas A Bowden
Journal:  Elife       Date:  2020-12-22       Impact factor: 8.140

Review 8.  Discovery of Antivirals Using Phage Display.

Authors:  Esen Sokullu; Marie-Soleil Gauthier; Benoit Coulombe
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.